Ignite Creation Date:
2025-12-24 @ 6:56 PM
Ignite Modification Date:
2026-02-20 @ 5:56 PM
Study NCT ID:
NCT03862157
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-30
First Post:
2019-01-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Myeloid Leukemia | View |
| None | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative | View |
| None | Chronic Eosinophilic Leukemia, Not Otherwise Specified | View |
| None | Chronic Myelomonocytic Leukemia | View |
| None | Chronic Neutrophilic Leukemia | View |
| None | Essential Thrombocythemia | View |
| None | Myelodysplastic Syndrome | View |
| None | Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis | View |
| None | Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable | View |
| None | Myeloid Neoplasm | View |
| None | Myeloproliferative Neoplasm | View |
| None | Myeloproliferative Neoplasm, Unclassifiable | View |
| None | Overt Primary Myelofibrosis | View |
| None | Polycythemia Vera | View |
| None | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | View |
| None | Prefibrotic/Early Primary Myelofibrosis | View |
Keywords: